Form 4 Tracker
Oruka Therapeutics, Inc.
ORKA

33 insider filings · Latest: Jul 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 15, 2026Apr 15 10:45 PMJoana GoncalvesChief Medical Officer
Sale
7,000$66.12$462.8K33,377(D)

View →

Apr 15, 2026Apr 15 8:54 PMJOANA GONCALVES
Proposed Sale
21,000$67.06$1.4M

View →

Mar 16, 2026Mar 17 8:10 PMLawrence Otto KleinDirector, Chief Executive Officer
Sale
1,729$41.30$71.4K927,309(D)

View →

Mar 16, 2026Mar 17 8:09 PMArjun AgarwalSenior Vice President, Finance
Sale
395$41.30$16.3K18,863(D)

View →

Mar 16, 2026Mar 17 8:08 PMLaura Lee SandlerChief Operating Officer
Sale
600$41.30$24.8K236,984(D)

View →

Mar 16, 2026Mar 17 8:06 PMJoana GoncalvesChief Medical Officer
Sale
7,641$40.91$312.6K33,377(D)

View →

Mar 16, 2026Mar 17 8:04 PMPaul T QuinlanGeneral Counsel
Sale
733$41.30$30.3K31,767(D)

View →

Mar 2, 2026Mar 2 11:47 PMLaura Lee SandlerChief Operating Officer
Sale
5,000$33.56$167.8K237,584(D)

View →

Feb 17, 2026Feb 17 10:24 PMJoana GoncalvesChief Medical Officer
Sale
7,000$32.37$226.6K34,018(D)

View →

Jan 15, 2026Jan 16 10:26 PMJoana GoncalvesChief Medical Officer
Sale
7,000$31.81$222.7K1,518(D)

View →

Jan 2, 2026Jan 2 9:31 PMLAURA SANDLER
Proposed Sale
18,000$30.31$545.6K

View →

Dec 19, 2025Dec 19 9:20 PMJOANA GONCALVES
Proposed Sale
28,000$28.15$788.2K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 23, 2026Jan 23 10:38 PMLawrence Otto KleinDirector, Chief Executive Officer
Grant/Award
306,700$34.39306,700(D)

View →

Jan 23, 2026Jan 23 10:36 PMPaul T QuinlanGeneral Counsel
Grant/Award
130,000$34.39130,000(D)

View →

Jan 15, 2026Jan 16 10:26 PMJoana GoncalvesChief Medical Officer
Option Exercise
7,000$7.80192,992(D)

View →

← Previous

Page 2 of 2